Atrial fibrillation: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• GLP-1 5
• SGLT2 5
• NLRP3 0
• BTK 3
• AMPK 0
• PI3K 0
• GIP 3
• PPAR 0
• TTR 0
• AKT 0
• PCSK9 0
• STAT3 0
• BDNF 1
• COX-2 0
• ERK 0
• HMGB1 0
• HSP90 0
• IL-6 0
• METTL3 0
• NRF2 0
• PD-1 0
• PD-L1 0
• TP53 0
• VEGF 0
• ABL1 0
• ALK 0
• ANGPTL3 0
• APOE 0
• CD40 0
• CDK4/6 0
• CFTR 0
• EGFR 0
• FTO 0
• HER3 0
• HIF-1 0
• IGF1R 0
• RUNX1 0
• SIRT1 0
• STING 0
• STK11 0
• TLR4 0
• TNF 0
• TREM2 0
• YAP 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Post Intensive Care Unit Atrial Fibrillation

  NCT05860894· Centre Hospitalier Universitaire de Besancon· Updated 22 Oct 2026

  “Insufficient recruitment”Registry text, quoted unchanged. Source

• Terminated

  Peripheral Nerve Stimulation Therapy for Atrial Fibrillation

  NCT05653583· Cala Health, Inc.· Updated 21 Oct 2026

  “The Sponsor and Principal Investigator have mutually agreed to initiate study closure due to prolonged recruitment challenges that have prevented the trial from meeting its enrollment milestones within the projected study timeline.”Registry text, quoted unchanged. Source

• Suspended

  A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

  NCT06168942· Jaguar LAA, Inc.· Updated 19 Oct 2026

  “Potential unwrapping of the LAA post implant with clinically significant leaks.”Registry text, quoted unchanged. Source

• Terminated

  Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

  NCT04624646· Ewha Womans University Mokdong Hospital· Updated 13 Oct 2026

  “Enrollment was closed early in July 2025 because of slow recruitment (338 of 600 planned participants; 324 were required for the superiority comparison). The 12-month follow-up period for all randomized participants ended in July 2026.”Registry text, quoted unchanged. Source

• Withdrawn

  Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

  NCT01422148· Baystate Medical Center· Updated 30 Sept 2026

  “NOT ENOUGH PARTICIPANTS”Registry text, quoted unchanged. Source

• Suspended

  The CONFORM Pivotal Trial

  NCT05147792· Conformal Medical, Inc· Updated 25 Sept 2026

  “Enrollment has been temporarily suspended out of an abundance of caution and in close consultation with trial leadership and regulatory bodies to review overall study data thoroughly following a serious adverse event.”Registry text, quoted unchanged. Source

• Withdrawn

  Sweet spoT for cArdiac Rhythm monitorinG After sTrokE

  NCT05717504· Luciano A. Sposato· Updated 18 Sept 2026

  “Withdrawn before enrollment because new clinical evidence made the study question no longer relevant.”Registry text, quoted unchanged. Source

• Terminated

  Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control

  NCT02025465· CAMC Health System· Updated 10 Sept 2026

  “Low enrollment and PI retired.”Registry text, quoted unchanged. Source

• Terminated

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Boston Scientific Corporation· Updated 25 Aug 2026

  “The enrollment was prematurely terminated on October 15, 2020, with 481 randomized patients. As discussed in the ASAP-TOO Update Meeting held on 16-September-2020 with FDA (Q150603-S001-A005), termination of enrollment was not due to safety concerns”Registry text, quoted unchanged. Source

• Withdrawn

  Connected Cardiology to Control Cardiac Rythm

  NCT06091514· Assistance Publique - Hôpitaux de Paris· Updated 25 Aug 2026

  “Decision by the manufacturer”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG

  NCT07918781· China National Center for Cardiovascular Diseases· Source

• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  NCT07175428· Regeneron Pharmaceuticals· Source

• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Regeneron Pharmaceuticals· Source

• A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

  NCT07429214· Biosense Webster, Inc.· Source

• Thrombolysis in Factor Xa-inhibitors Trial

  NCT06878066· Guri Hagberg· Source

• A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation

  NCT07845682· Biosense Webster, Inc.· Source

• A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

  NCT07511166· Johnson & Johnson Medical (Shanghai) Ltd.· Source

• A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

  NCT07227532· Biosense Webster, Inc.· Source

• A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

  NCT07116525· Biosense Webster, Inc.· Source

• A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

  NCT07788989· Biosense Webster, Inc.· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 5
• Organoids 1
• Mendelian Randomization Analysis 75
• Gene Expression Profiling 31
• Whole Genome Sequencing 1
• Exome Sequencing 3
• Proteomics 16
• Metabolomics 13
• Mass Spectrometry 3
• Flow Cytometry 2
• Immunohistochemistry 2
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 67
• Machine Learning 85
• Deep Learning 35
• Cohort Studies 215
• Genome-Wide Association Study 62

• Prediction of Atrial Fibrillation Occurrence With Handheld Mobile Electrocardiogram: Deep Learning Model Development Using Real-World Data.

  JMIR Med Inform, Aug 2026

• Validation of a deep learning-based system for sleep staging, arousal detection, and respiratory event scoring in atrial fibrillation patients.

  J Clin Sleep Med, Aug 2026

• Deep learning prediction of left atrial structure and function from 12-lead electrocardiograms.

  Nat Commun, Jul 2026

• R-R Interval Histogram-Based Deep Learning for 3-Class Atrial Fibrillation Screening in Garment-Type Wearable Holter Electrocardiogram Monitoring: Algorithm Development and Validation Study.

  JMIR Med Inform, Jul 2026

• Deep Learning-Based Dynamic Segmentation of the Left Atrium in 4D Flow MRI.

  Magn Reson Med, Jul 2026

• A comprehensive inference-time augmentation framework in physiological signals: application to PPG-based AF detection.

  Physiol Meas, Jul 2026

• Cross-domain transfer learning strategy enhances interpretability of deep learning model explanations.

  Sci Rep, Jun 2026

• Clinically-aligned explainable AI for atrial fibrillation detection: A U-Net inspired multi-lead ECG analysis framework.

  Comput Methods Programs Biomed, Jun 2026

• MD-ViSCo: A Unified Model for Multi-Directional Vital Sign Waveform Conversion.

  IEEE J Biomed Health Inform, Jun 2026

• ECG Signatures and Long-Term Ischemic Stroke Risk: A Deep Learning Analysis of 200,000 Patients.

  J Am Coll Cardiol, May 2026

See which targets of this disease your abstract mentions, and go to the people working on them.